THC Form 4: EVP/COO Disposes of 8,000 Shares; Weighted Avg $179.53

Rhea-AI Filing Summary

Lisa Y. Foo, Executive Vice President and Chief Operating Officer of Tenet Healthcare Corporation (THC), reported the sale of 8,000 shares of Tenet common stock on 08/20/2025 at a weighted average price of $179.53 per share. After the reported disposition, the reporting person beneficially owned 20,878 shares, held directly. The Form 4 was signed by an attorney-in-fact, Chad J. Wiener, on 08/22/2025. The filer indicates the aggregate sale included multiple transactions with prices ranging from $179.22 to $179.74, and offers to provide detailed per-transaction quantities on request.

Insights

Securities Analyst

TL;DR: Insider sale of 8,000 shares was disclosed and appears routine; no additional company-level financial data provided.

The Form 4 documents a clear, compliant disclosure of an insider disposition by the EVP/COO. The filing provides the weighted average sale price and a range of execution prices, and records post-transaction beneficial ownership. Because the filing contains only the transaction details and no corporate performance metrics, it does not permit assessment of motive or material impact on company valuation. Impact to investors is limited to the transparency value of timely insider reporting.

Corporate Governance Expert

TL;DR: The disclosure meets Section 16 reporting requirements and documents an attorney-in-fact signature.

The Form 4 shows the officer-level reporting person filed through an attorney-in-fact and included an explanation of the weighted average price and price range. From a governance perspective, the filing demonstrates procedural compliance with insider transaction reporting. The document contains no indication of unusual or extraordinary transactions beyond an ordinary sale of shares, and it does not disclose any trading plan or contract tied to the sale.

Insider Trade Summary

Net Seller: 8,000 shares

Net Sell 1 txn

Insider Foo Lisa Y

Role EVP, Chief Operating Officer

Sold 8,000 shs ($1.44M)

Type	Security	Shares	Price	Value
Sale	Common Stock	8,000	$179.53	$1.44M

Holdings After Transaction: Common Stock — 20,878 shares (Direct)

Footnotes (1)

1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $179.22 to $179.74. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 08/22/2025 - 08:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Tenet Healthcare (THC) disclose on this Form 4?

The filing reports that Lisa Y. Foo, EVP and COO, sold 8,000 shares on 08/20/2025 at a weighted average price of $179.53 per share.

How many Tenet shares does the reporting officer own after the sale?

After the reported disposition the reporting person beneficially owned 20,878 shares, held directly.

What price range did the insider sale occur at?

The filer disclosed the sale occurred in multiple transactions at prices ranging from $179.22 to $179.74, with a weighted average of $179.53.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Chad J. Wiener as attorney-in-fact for Lisa Y. Foo on 08/22/2025.

Does the Form 4 state whether the transaction was part of a trading plan?

No. The filing does not indicate the sale was made pursuant to a Rule 10b5-1 trading plan or other written plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foo Lisa Y

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		S		8,000	D	$179.53(1)	20,878	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $179.22 to $179.74. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	Chad J. Wiener as Attorney-in-Fact for Lisa Y. Foo	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.